@techcrunch.com 2 months ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@tech.eu 1 year ago
Amadeus Capital Partners’ Volker Hirsch joins Medicines Discovery Catapult as Chief Commercial Officer
@xconomy.com 5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision